Aquestive Therapeutics IncNASDAQ:AQST
- LAST PRICE5.4600
- TODAY'S CHANGE (%)0.3800 (7.4803%)
- Bid / Lots5.2600/ 3
- Ask / Lots5.4500/ 2
- Open / Previous Close5.1000 / 5.0800
- Day Range
- 52 Week Range
- Volume1,742,587
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | AQST |
|---|---|---|
| 09:32 ET | 15073 | 4.98 |
| 09:33 ET | 11085 | 5.02 |
| 09:35 ET | 5410 | 5.045 |
| 09:37 ET | 100 | 5.04 |
| 09:39 ET | 850 | 5.0539 |
| 09:42 ET | 12787 | 5.05 |
| 09:44 ET | 2228 | 5.07 |
| 09:46 ET | 2300 | 5.086 |
| 09:48 ET | 1500 | 5.12 |
| 09:50 ET | 2452 | 5.145 |
| 09:51 ET | 2230 | 5.14 |
| 09:53 ET | 2329 | 5.13 |
| 09:55 ET | 1252 | 5.12 |
| 09:57 ET | 3772 | 5.115 |
| 10:00 ET | 9991 | 5.12 |
| 10:02 ET | 5513 | 5.105 |
| 10:04 ET | 800 | 5.12 |
| 10:06 ET | 4063 | 5.11 |
| 10:08 ET | 1500 | 5.105 |
| 10:09 ET | 100 | 5.105 |
| 10:11 ET | 3900 | 5.1 |
| 10:13 ET | 5272 | 5.12 |
| 10:15 ET | 2231 | 5.12 |
| 10:18 ET | 4836 | 5.11 |
| 10:20 ET | 4900 | 5.105 |
| 10:22 ET | 2581 | 5.135 |
| 10:24 ET | 4200 | 5.15 |
| 10:26 ET | 100 | 5.15 |
| 10:27 ET | 7043 | 5.145 |
| 10:29 ET | 4080 | 5.15 |
| 10:31 ET | 1556 | 5.1504 |
| 10:33 ET | 4838 | 5.165 |
| 10:36 ET | 6618 | 5.175 |
| 10:38 ET | 800 | 5.18 |
| 10:40 ET | 118358 | 5.195 |
| 10:42 ET | 8150 | 5.1801 |
| 10:44 ET | 6791 | 5.2 |
| 10:45 ET | 12979 | 5.18 |
| 10:47 ET | 5876 | 5.16 |
| 10:49 ET | 3912 | 5.13 |
| 10:51 ET | 7278 | 5.11 |
| 10:54 ET | 4414 | 5.135 |
| 10:56 ET | 734 | 5.15 |
| 10:58 ET | 200 | 5.15 |
| 11:00 ET | 1800 | 5.145 |
| 11:02 ET | 783 | 5.15 |
| 11:03 ET | 2943 | 5.145 |
| 11:05 ET | 2746 | 5.14 |
| 11:07 ET | 2479 | 5.155 |
| 11:09 ET | 300 | 5.16 |
| 11:12 ET | 600 | 5.155 |
| 11:14 ET | 1000 | 5.15 |
| 11:16 ET | 2338 | 5.14 |
| 11:18 ET | 12717 | 5.15 |
| 11:20 ET | 306 | 5.155 |
| 11:21 ET | 3170 | 5.17 |
| 11:23 ET | 2051 | 5.165 |
| 11:25 ET | 3698 | 5.165 |
| 11:27 ET | 800 | 5.17 |
| 11:30 ET | 3738 | 5.1792 |
| 11:32 ET | 19424 | 5.205 |
| 11:34 ET | 7918 | 5.205 |
| 11:36 ET | 500 | 5.21 |
| 11:38 ET | 3194 | 5.22 |
| 11:39 ET | 2933 | 5.21 |
| 11:41 ET | 7320 | 5.2243 |
| 11:43 ET | 2657 | 5.2101 |
| 11:45 ET | 3756 | 5.205 |
| 11:48 ET | 2113 | 5.2001 |
| 11:50 ET | 2698 | 5.21 |
| 11:52 ET | 58084 | 5.235 |
| 11:54 ET | 9179 | 5.255 |
| 11:56 ET | 7671 | 5.27 |
| 11:57 ET | 4180 | 5.255 |
| 11:59 ET | 3792 | 5.24 |
| 12:01 ET | 3883 | 5.26 |
| 12:03 ET | 400 | 5.26 |
| 12:06 ET | 350 | 5.2532 |
| 12:08 ET | 7109 | 5.26 |
| 12:10 ET | 769 | 5.27 |
| 12:12 ET | 200 | 5.2664 |
| 12:14 ET | 15573 | 5.26 |
| 12:15 ET | 24706 | 5.255 |
| 12:17 ET | 672 | 5.255 |
| 12:19 ET | 4745 | 5.275 |
| 12:21 ET | 1052 | 5.29 |
| 12:24 ET | 1488 | 5.29 |
| 12:26 ET | 3822 | 5.29 |
| 12:28 ET | 2400 | 5.295 |
| 12:30 ET | 6423 | 5.2901 |
| 12:32 ET | 8672 | 5.285 |
| 12:33 ET | 9080 | 5.29 |
| 12:35 ET | 2200 | 5.3 |
| 12:37 ET | 36920 | 5.31 |
| 12:39 ET | 7435 | 5.325 |
| 12:42 ET | 1000 | 5.325 |
| 12:44 ET | 7192 | 5.315 |
| 12:46 ET | 1288 | 5.315 |
| 12:48 ET | 5986 | 5.325 |
| 12:50 ET | 915 | 5.33 |
| 12:51 ET | 200 | 5.328 |
| 12:53 ET | 600 | 5.325 |
| 12:55 ET | 2153 | 5.33 |
| 12:57 ET | 8153 | 5.325 |
| 01:00 ET | 4157 | 5.315 |
| 01:02 ET | 2017 | 5.315 |
| 01:04 ET | 300 | 5.315 |
| 01:06 ET | 9738 | 5.315 |
| 01:08 ET | 5039 | 5.315 |
| 01:09 ET | 899 | 5.315 |
| 01:11 ET | 1000 | 5.3101 |
| 01:13 ET | 10114 | 5.305 |
| 01:15 ET | 8503 | 5.335 |
| 01:18 ET | 10508 | 5.3674 |
| 01:20 ET | 3681 | 5.38 |
| 01:22 ET | 865 | 5.38 |
| 01:24 ET | 4840 | 5.381 |
| 01:26 ET | 693 | 5.38 |
| 01:27 ET | 66734 | 5.435 |
| 01:29 ET | 6691 | 5.45 |
| 01:31 ET | 5512 | 5.45 |
| 01:33 ET | 14930 | 5.46 |
| 01:36 ET | 14065 | 5.48 |
| 01:38 ET | 8774 | 5.479 |
| 01:40 ET | 7786 | 5.495 |
| 01:42 ET | 49574 | 5.475 |
| 01:44 ET | 6224 | 5.478 |
| 01:45 ET | 14460 | 5.485 |
| 01:47 ET | 34477 | 5.465 |
| 01:49 ET | 5145 | 5.455 |
| 01:51 ET | 4607 | 5.455 |
| 01:54 ET | 11026 | 5.455 |
| 01:56 ET | 8879 | 5.455 |
| 01:58 ET | 1325 | 5.455 |
| 02:00 ET | 1200 | 5.45 |
| 02:02 ET | 43517 | 5.405 |
| 02:03 ET | 5198 | 5.395 |
| 02:05 ET | 9697 | 5.39 |
| 02:07 ET | 3857 | 5.3801 |
| 02:09 ET | 1700 | 5.39 |
| 02:12 ET | 5684 | 5.415 |
| 02:14 ET | 2272 | 5.43 |
| 02:16 ET | 400 | 5.435 |
| 02:18 ET | 20850 | 5.42 |
| 02:20 ET | 589 | 5.429 |
| 02:21 ET | 892 | 5.43 |
| 02:23 ET | 1800 | 5.44 |
| 02:25 ET | 2837 | 5.45 |
| 02:27 ET | 2065 | 5.445 |
| 02:30 ET | 1717 | 5.445 |
| 02:32 ET | 900 | 5.45 |
| 02:34 ET | 607 | 5.4413 |
| 02:36 ET | 2557 | 5.46 |
| 02:38 ET | 3573 | 5.465 |
| 02:39 ET | 6515 | 5.465 |
| 02:41 ET | 1100 | 5.48 |
| 02:43 ET | 400 | 5.48 |
| 02:45 ET | 3700 | 5.49 |
| 02:48 ET | 29876 | 5.475 |
| 02:50 ET | 2294 | 5.485 |
| 02:52 ET | 16791 | 5.475 |
| 02:54 ET | 1200 | 5.475 |
| 02:56 ET | 942 | 5.48 |
| 02:57 ET | 3425 | 5.475 |
| 02:59 ET | 7870 | 5.46 |
| 03:01 ET | 12199 | 5.48 |
| 03:03 ET | 2403 | 5.475 |
| 03:06 ET | 1596 | 5.48 |
| 03:08 ET | 1100 | 5.485 |
| 03:10 ET | 1400 | 5.485 |
| 03:12 ET | 1060 | 5.485 |
| 03:14 ET | 8721 | 5.475 |
| 03:15 ET | 11307 | 5.46 |
| 03:17 ET | 6493 | 5.475 |
| 03:19 ET | 29927 | 5.5 |
| 03:21 ET | 47277 | 5.475 |
| 03:24 ET | 300 | 5.475 |
| 03:26 ET | 523 | 5.48 |
| 03:28 ET | 1969 | 5.475 |
| 03:30 ET | 7646 | 5.4611 |
| 03:32 ET | 1550 | 5.46 |
| 03:33 ET | 13065 | 5.445 |
| 03:35 ET | 6557 | 5.445 |
| 03:37 ET | 9806 | 5.44 |
| 03:39 ET | 3245 | 5.435 |
| 03:42 ET | 1684 | 5.435 |
| 03:44 ET | 11676 | 5.44 |
| 03:46 ET | 7479 | 5.45 |
| 03:48 ET | 1596 | 5.45 |
| 03:50 ET | 14714 | 5.465 |
| 03:51 ET | 16983 | 5.465 |
| 03:53 ET | 13041 | 5.5 |
| 03:55 ET | 9574 | 5.4999 |
| 03:57 ET | 74283 | 5.46 |
| 04:00 ET | 102719 | 5.46 |
Nov 6, 2024
DJ Aquestive Therapeutics Price Target Maintained With a $10.00/Share by HC Wainwright & Co., from 7:30AM ET on Wednesday Nov 06, 2024 by Dow Jones
7:30AM ET on Wednesday Nov 06, 2024 by Dow Jones
Nov 4, 2024
Aquestive Therapeutics Reports Third Quarter 2024 Financial Results and Provides Business Update, from 4:36PM ET on Monday Nov 04, 2024 by Dow Jones
4:36PM ET on Monday Nov 04, 2024 by Dow Jones*DJ Aquestive Therapeutics 3Q Loss/Shr 13c >AQST, from 4:36PM ET on Monday Nov 04, 2024 by Dow Jones
4:36PM ET on Monday Nov 04, 2024 by Dow Jones
Oct 25, 2024
DJ Aquestive Therapeutics Is Maintained at Outperform by Leerink Partners, from 9:31AM ET on Friday Oct 25, 2024 by Dow Jones
9:31AM ET on Friday Oct 25, 2024 by Dow JonesAquestive Therapeutics to Present Subsequent Analysis of Pivotal Study for Anaphylm(TM) (epinephrine) Sublingual Film Demonstrating Comparable PK and PD Data to Epinephrine Injection Regardless of Variable Placement or Intraoral Movement at American College of Allergy Asthma and Immunology (ACAAI) 2024 Annual Meeting, from 8:00AM ET on Friday Oct 25, 2024 by Dow Jones
8:00AM ET on Friday Oct 25, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Aquestive Therapeutics Inc | 497.8M | -15.3x | --- |
Theravance Biopharma Inc | 437.4M | -9.7x | --- |
Daiichi Sankyo Co Ltd | 62.0B | 37.1x | --- |
Sanara Medtech Inc | 308.2M | -45.2x | --- |
Biostem Technologies Inc | 371.3M | 68.1x | --- |
EyePoint Pharmaceuticals Inc | 792.0M | -5.8x | --- |
Company Information
Aquestive Therapeutics, Inc. is a pharmaceutical company. The Company is developing pharmaceutical products to deliver complex molecules through administrations that are alternatives to invasive and inconvenient standard of care therapies. It is advancing a product pipeline for the treatment of severe allergic reactions, including anaphylaxis. It has also developed a product pipeline focused on treating diseases of the central nervous system (CNS). Its PharmFilm technology is comprised of proprietary polymer compositions that serve as film formers to hold active pharmaceutical ingredients (APIs), and excipients in place. Its product portfolio and pipeline include Anaphylm, AQST-108, and Adrenaverse. Its CNS product candidate include Libervant. The Company’s Licensed commercial products and product candidates and other product includes Suboxone, Exservan, KYNMOBI, Zuplenz, Azstarys, Libervant, and Sympazan. Anaphylm is a non-device based, orally delivered epinephrine product candidate.
Contact Information
- Headquarters
- 30 Technology DrWARREN, NJ, United States 07059-5166
- Phone
- 908-941-1900
- Fax
- 302-636-5454
Executives
- Independent Chairman of the Board
- Gregory Brown
- President, Chief Executive Officer, Director
- Daniel Barber
- Independent Vice Chairman of the Board
- John Cochran
- Chief Financial Officer
- A. Ernest Toth
- Chief Operating Officer
- Cassie Jung
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $497.8M |
|---|---|
Revenue (TTM) | $58.4M |
Shares Outstanding | 91.2M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 2.65 |
EPS | $-0.36 |
Book Value | $-1.55 |
P/E Ratio | -15.3x |
Price/Sales (TTM) | 8.5 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -27.79% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
